Search Results

You are looking at 1 - 9 of 9 items for :

  • "nodular thyroid disease" x
  • Refine by Access: All content x
Clear All
Open access

Irfan Vardarli, Manuel Weber, Frank Weidemann, Dagmar Führer, Ken Herrmann, and Rainer Görges

and corresponds to 1–3% of all histologically proven thyroid cancers in the United States, with a prevalence of 0.1–1.4% in patients with nodular thyroid disease ( 2 , 4 ), appearing either sporadically or in a hereditary form as a component of the

Open access

Paolo G Arduino, Dora Karimi, Federico Tirone, Veronica Sciannameo, Fulvio Ricceri, Marco Cabras, Alessio Gambino, Davide Conrotto, Stefano Salzano, Mario Carbone, and Roberto Broccoletti

Normal 303 (98.7%) 241 (99.6%) Low 4 (1.3%) 0 (0%) Elevated 0 (0%) 1 (0.4%)   P -value = 0.08 Thyroid disease positive patients No. 71 (/307) No. 22 (/242) Nodular thyroid diseases 9 (12.7%) 3 (13

Open access

John E M Midgley, Rolf Larisch, Johannes W Dietrich, and Rudolf Hoermann

, autoimmune thyroiditis; Goitre, goitre post surgery for benign nodular thyroid disease. Median thyroid volume was 0 ml (IQR 0, 0 ml) in carcinomas, 7 ml (IQR 4, 11 ml) in autoimmune thyroiditis and 6 ml (IQR 3, 8 ml) in benign goitre post surgery. The weight

Open access

Helle Døssing, Finn Noe Bennedbæk, and Laszlo Hegedüs

inclusion. Discussion Over the last 10–15 years LT has increasingly, together with other thermal ablation techniques, been accepted as an alternative to surgery in selected patients with benign nodular thyroid disease ( 13 , 18 , 19

Open access

Zhenzhen Wang, Xiangying Zhu, Xiaohui Yu, Haixia Guan, Lei Zhao, Yixia Zhang, Yuge Li, Liang Sang, Yuchen Han, Yushu Li, Zhongyan Shan, and Weiping Teng

Introduction Nodular thyroid disease is common in endocrine practice. In iodine-sufficient areas, the thyroid nodule detection rate, as determined by palpation, is 5% in women and 1% in men ( 1 , 2 ), whereas the detection rate, as determined

Open access

Ling Hu, Ting Li, Xiao-Ling Yin, and Yi Zou

-6999.20140246 ) 11 Fiore E Vitti P . Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease . Journal of Clinical Endocrinology and Metabolism 2012 97 1134 – 11 45. ( https://doi.org/10.1210/jc.2011-2735 ) 12 Qiu L . Study on

Open access

Melinda Kertész, Szilárd Kun, Eszter Sélley, Zsuzsanna Nagy, Tamás Kőszegi, and István Wittmann

study, the association of subclinical hypothyroidism and complications of type 2 diabetes was proved ( 11 ). Recently, an increased prevalence of nodular thyroid disease in metabolic syndrome has been detected ( 12 ). Moreover, high T3 may predict

Open access

Peter D Mark, Mikkel Andreassen, Claus L Petersen, Andreas Kjaer, and Jens Faber

in the elderly and can be divided into either endogenous causes most often due to autonomous nodular thyroid disease, or exogenous causes due to suppressive therapy with thyroid hormones in thyroid cancer or goiter or overtreatment of hypothyroidism

Open access

Katerina Saltiki, Elli Anagnostou, George Simeakis, Sofia Kouki, Anastasia Angelopoulou, Leda Sarika, Alexandra Papathoma, and Maria Alevizaki

≤1 year and/or new or increasing size lesions had ‘progressive disease’ ( 14 ). Calcitonin screening has been routinely performed at our center since 2001 in patients with nodular thyroid disease. From 2006 to 2012, calcitonin was measured using a